ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Quick take on safety: bonds vs cash in retirement, highlighting scenarios where each preserves capital and meets withdrawal needs.
24,731 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Rivian is set to unveil the R2 on March 12, a mass-market SUV that could determine the company’s profitability and st...
Lucid’s Gravity starts at $95,000 with a 450-mile range, claiming superiority over high-powered ICE rivals. The compa...
A small group of under-the-radar stocks is flashing AI-like growth signals while remaining off the radar of most inve...
Investors have watched quantum stocks climb even amid mixed news. This guide explains the forces fueling the rally, h...
OpenAI and SpaceX confront a profitability horizon that stretches into the 2030s. The classic Good Money framework as...
Two consumer-staple giants posted results that intensify the dividend comparison between P&G and Colgate-Palmolive, a...
Nuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
Synopsys rides AI-driven demand in EDA and IP, delivering solid quarterly results and a robust backlog as the AI buil...
Warren Buffett publicly stated he initiated Berkshire Hathaway’s larger stake in Alphabet, signaling a top-down push ...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...
A fresh stake in SSR Mining hints at growing conviction in gold exposure. This article breaks down what the stake mea...